RecruitingPhase IMale onlyEN originalProstate cancerMetastatic / advanced

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate Cancer.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Potwierdzony nowotwór złośliwy gruczołu krokowego (rak prostaty)
  • Ogólny stan zdrowia pozwalający na uczestnictwo w badaniu
  • Podwyższone markery raka prostaty (PSA ≥ 2 ng/mL)
  • Progresja choroby pomimo leczenia hormonalnego i co najmniej jednego dodatkowego leku

✗ Disqualifies

  • Przerzuty do mózgu w przeszłości
  • Poważne problemy z sercem lub choroby serca
  • Aktywne infekcje, zaburzenia psychiczne lub inne schorzenia stanowiące zagrożenie dla bezpieczeństwa uczestnika

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
August 10, 2026
Sex
Male only

Therapies / drugs in trial

Locations (15)

Stanford Cancer Center

Palo Alto, United States

Florida Cancer Specialists Sarasota Drug Development Unit

Sarasota, United States

Dana-Farber Cancer Institute

Boston, United States

Memorial Sloan Kettering Cancer Center

New York, United States

Duke Cancer Institute

Durham, United States

Local Institution - 0006

San Antonio, United States

NEXT Oncology

San Antonio, United States

Fred Hutchinson Cancer Center

Seattle, United States

Local Institution - 0009

Toronto, Canada

Local Institution - 0011

Montreal, Canada

Local Institution - 0018

Bordeaux, France

Centre Leon Berard

Lyon Cedex08, France

Institut Paoli-Calmettes

Marseille, France

Gustave Roussy

Villejuif, France

Local Institution - 0017

Paris, France

Trial contact

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

First line of the email MUST contain NCT # and Site #.

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/11/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.